These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36369498)

  • 21. The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia.
    Espinosa G; Prieto-González S; Llevadot M; Marco-Hernández J; Martínez-Artuña A; Pérez-Isidro A; Rifé E; Cervera R
    Clin Rheumatol; 2021 May; 40(5):2057-2063. PubMed ID: 33677725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoids' treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients.
    Garcia-Cirera S; Calvet J; Berenguer-Llergo A; Pradenas E; Marfil S; Massanella M; Mateu L; Trinité B; Llop M; Arévalo M; Galisteo C; Orellana C; Gómez R; Gómez-Gerique MN; Carmona I; Clotet B; Blanco J; Gratacós J
    Sci Rep; 2022 Aug; 12(1):14772. PubMed ID: 36042275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
    Barbhaiya M; Levine JM; Siegel CH; Bykerk VP; Jannat-Khah D; Mandl LA
    Clin Rheumatol; 2022 May; 41(5):1619-1622. PubMed ID: 34716843
    [No Abstract]   [Full Text] [Related]  

  • 24. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.
    Moyon Q; Sterlin D; Miyara M; Anna F; Mathian A; Lhote R; Ghillani-Dalbin P; Breillat P; Mudumba S; de Alba S; Cohen-Aubart F; Haroche J; Pha M; Boutin THD; Chaieb H; Flores PM; Charneau P; Gorochov G; Amoura Z
    Ann Rheum Dis; 2022 Apr; 81(4):575-583. PubMed ID: 34607791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
    Sukhdeo S; Negroponte E; Rajasekhar H; Gaur S; Horton DB; Malhotra A; Moorthy LN
    Lupus; 2021 Apr; 30(5):836-839. PubMed ID: 33509065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report.
    Molina-Rios S; Rojas-Martinez R; Estévez-Ramirez GM; Medina YF
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):43-46. PubMed ID: 35246682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and risk of disease flare after a three-dose regimen with SARS-CoV-2 vaccination in patients with systemic lupus erythematosus: results from the prospective cohort study COVAC-SLE.
    Larsen ES; Nilsson AC; Möller S; Voss AB; Johansen IS
    Clin Exp Rheumatol; 2023 Mar; 41(3):676-684. PubMed ID: 35894059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination.
    Zavala-Miranda MF; González-Ibarra SG; Pérez-Arias AA; Uribe-Uribe NO; Mejia-Vilet JM
    Kidney Int; 2021 Dec; 100(6):1340-1341. PubMed ID: 34560139
    [No Abstract]   [Full Text] [Related]  

  • 29. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection.
    Bonometti R; Sacchi MC; Stobbione P; Lauritano EC; Tamiazzo S; Marchegiani A; Novara E; Molinaro E; Benedetti I; Massone L; Bellora A; Boverio R
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9695-9697. PubMed ID: 33015814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 vaccines in patients with SLE.
    Tang W; Askanase AD; Khalili L; Merrill JT
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33685998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience.
    Monte G; Papetti L; Ferilli MAN; Ursitti F; Moavero R; Sforza G; Panella E; Tarantino S; Checchi MP; Vigevano F; Palma P; Valeriani M
    Front Immunol; 2023; 14():1106472. PubMed ID: 36761740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.
    Kreuter A; Burmann SN; Burkert B; Oellig F; Michalowitz AL
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e733-e735. PubMed ID: 34243220
    [No Abstract]   [Full Text] [Related]  

  • 33. New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2.
    Gamonal SBL; Marques NCV; Pereira HMB; Gamonal ACC
    Dermatol Ther; 2022 Sep; 35(9):e15677. PubMed ID: 35770484
    [No Abstract]   [Full Text] [Related]  

  • 34. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.
    Mathian A; Breillat P; Dorgham K; Bastard P; Charre C; Lhote R; Quentric P; Moyon Q; Mariaggi AA; Mouries-Martin S; Mellot C; Anna F; Haroche J; Cohen-Aubart F; Sterlin D; Zahr N; Gervais A; Le Voyer T; Bizien L; Amiot Q; Pha M; Hié M; Chasset F; Yssel H; Miyara M; Charneau P; Ghillani-Dalbin P; Casanova JL; Rozenberg F; Amoura Z; Gorochov G
    Ann Rheum Dis; 2022 Dec; 81(12):1695-1703. PubMed ID: 35973806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab.
    Schiavoni I; Olivetta E; Natalucci F; Olivieri G; Lo Presti A; Fedele G; Stefanelli P; Ceccarelli F; Conti F
    Lupus; 2023 Mar; 32(3):394-400. PubMed ID: 36607313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: A Fatal Case of West Nile Virus Meningoencephalomyelitis in a Woman with Systemic Lupus Erythematosus Initially Misdiagnosed as SARS-CoV-2 Infection.
    Schiuma M; Pezzati L; Ballone E; Borghi B; Osio M; Mattavelli D; Galimberti L; Corbellino M; Mileto D; Zanchetta N; Antinori S
    Am J Trop Med Hyg; 2021 Mar; 104(5):1716-1718. PubMed ID: 33782207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
    Raiker R; Pakhchanian H; DeYoung C; Gupta L; Kardeş S; Ahmed S; Kavadichanda C
    J Autoimmun; 2021 Dec; 125():102730. PubMed ID: 34649723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort.
    Choi MY; Clarke AE; Buhler K; Jung M; Mathew H; Zhang M; Cardwell FS; Waldhauser H; Fritzler MJ
    Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35393285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic lupus erythematosus manifestation following COVID-19: a case report.
    Zamani B; Moeini Taba SM; Shayestehpour M
    J Med Case Rep; 2021 Jan; 15(1):29. PubMed ID: 33494816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.